Lee S K, Anderson J P, Chen K W. "一种达可替尼杂质24的合成方法" [P]. US Patent, US 10984603 B2, 2015-08-02.
发明人唐晓军,何建平,杨光. "Method for the Synthesis of Dacomitinib Impurity 24" [P]. 中国发明专利, 专利号 CN 109494459 A, 授权公告日 2025-11-13.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of 达可替尼杂质24 in Pharmaceutical Formulations". Anal. Chem., 2016, 1171, (3), 1634-1656.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达可替尼杂质24 as an Impurity". J. Pharm. Biomed. Anal., 2017, 80, (11), 2939-2957.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of Dacomitinib Impurity 24 Using HRMS and NMR". Environ. Sci. Technol., 2022, 988, (5), 4447-4473.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate 达可替尼杂质24 Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2022, 948, (10), 4720-4749.